Clinical Report
iPCSK9 treatment of familial hypercholesterolemia in a patient diagnosed as congenital muscular dystrophy with contraindication for statin use
Tratamiento de la hipercolesterolemia familiar con iPCSK9 en un paciente diagnosticado de distrofia muscular congénita con contraindicación para la toma de estatinas
Sergio Arnedo Hernández
, José Daniel Mosquera Lozano, Iratxe Martínez de Narvajas Urra, Estela Menéndez Fernández, Elisa Rabadán Pejenaute, Ramón Baeza Trinidad, Marta Casañas Martínez, Angel Brea Hernando
Corresponding author
Unidad de Lípidos, Servicio de Medicina Interna, Hospital San Pedro, Logroño, La Rioja, Spain
Read
2690
Timeswas read the article
482
Total PDF
2208
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 12 | 35 | 3 | 38 |
| 2025 11 | 128 | 28 | 156 |
| 2025 10 | 73 | 21 | 94 |
| 2025 9 | 68 | 18 | 86 |
| 2025 8 | 76 | 15 | 91 |
| 2025 7 | 89 | 12 | 101 |
| 2025 6 | 66 | 7 | 73 |
| 2025 5 | 73 | 5 | 78 |
| 2025 4 | 33 | 3 | 36 |
| 2025 3 | 50 | 3 | 53 |
| 2025 2 | 44 | 7 | 51 |
| 2025 1 | 54 | 4 | 58 |
| 2024 12 | 37 | 4 | 41 |
| 2024 11 | 45 | 3 | 48 |
| 2024 10 | 46 | 16 | 62 |
| 2024 9 | 68 | 24 | 92 |
| 2024 8 | 44 | 15 | 59 |
| 2024 7 | 49 | 7 | 56 |
| 2024 6 | 51 | 6 | 57 |
| 2024 5 | 46 | 5 | 51 |
| 2024 4 | 48 | 7 | 55 |
| 2024 3 | 29 | 4 | 33 |
| 2024 2 | 50 | 5 | 55 |
| 2024 1 | 50 | 6 | 56 |
| 2023 12 | 41 | 17 | 58 |
| 2023 11 | 51 | 24 | 75 |
| 2023 10 | 57 | 20 | 77 |
| 2023 9 | 44 | 14 | 58 |
| 2023 8 | 54 | 12 | 66 |
| 2023 7 | 53 | 18 | 71 |
| 2023 6 | 45 | 17 | 62 |
| 2023 5 | 99 | 18 | 117 |
| 2023 4 | 67 | 7 | 74 |
| 2023 3 | 40 | 10 | 50 |
| 2023 2 | 40 | 7 | 47 |
| 2023 1 | 36 | 6 | 42 |
| 2022 12 | 38 | 8 | 46 |
| 2022 11 | 28 | 4 | 32 |
| 2022 10 | 26 | 8 | 34 |
| 2022 9 | 27 | 9 | 36 |
| 2022 8 | 28 | 11 | 39 |
| 2022 7 | 25 | 6 | 31 |
| 2022 6 | 14 | 10 | 24 |
| 2022 5 | 13 | 5 | 18 |
| 2022 4 | 12 | 10 | 22 |
| 2022 3 | 10 | 11 | 21 |
| 2022 2 | 8 | 2 | 10 |
Show all